AO Cannizzaro

Catania 95126

2 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Endometrial Cancer, Inflammation, Low Grade Serous Ovarian Cancer

Studies at this site

• A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer — Recruiting now
• Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed